ARTIVION INC (AORT) Fundamental Analysis & Valuation

NYSE:AORT • US2289031005

Current stock price

37.825 USD
+0.43 (+1.14%)
Last:

This AORT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. AORT Profitability Analysis

1.1 Basic Checks

  • In the past year AORT was profitable.
  • In the past year AORT had a positive cash flow from operations.
  • In the past 5 years AORT reported 4 times negative net income.
  • In multiple years AORT reported negative operating cash flow during the last 5 years.
AORT Yearly Net Income VS EBIT VS OCF VS FCFAORT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M

1.2 Ratios

  • The Return On Assets of AORT (1.10%) is better than 72.83% of its industry peers.
  • The Return On Equity of AORT (2.18%) is better than 73.37% of its industry peers.
  • AORT has a Return On Invested Capital of 2.26%. This is in the better half of the industry: AORT outperforms 69.57% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for AORT is significantly below the industry average of 9.18%.
Industry RankSector Rank
ROA 1.1%
ROE 2.18%
ROIC 2.26%
ROA(3y)-1.48%
ROA(5y)-1.76%
ROE(3y)-4.5%
ROE(5y)-5.02%
ROIC(3y)2.51%
ROIC(5y)N/A
AORT Yearly ROA, ROE, ROICAORT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 -10

1.3 Margins

  • AORT's Profit Margin of 2.21% is fine compared to the rest of the industry. AORT outperforms 73.37% of its industry peers.
  • With a decent Operating Margin value of 6.06%, AORT is doing good in the industry, outperforming 71.20% of the companies in the same industry.
  • In the last couple of years the Operating Margin of AORT has grown nicely.
  • The Gross Margin of AORT (64.40%) is better than 69.02% of its industry peers.
  • AORT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.06%
PM (TTM) 2.21%
GM 64.4%
OM growth 3YN/A
OM growth 5Y12.17%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.07%
GM growth 5Y-0.57%
AORT Yearly Profit, Operating, Gross MarginsAORT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. AORT Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AORT is destroying value.
  • AORT has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, AORT has more shares outstanding
  • AORT has a better debt/assets ratio than last year.
AORT Yearly Shares OutstandingAORT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
AORT Yearly Total Debt VS Total AssetsAORT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • An Altman-Z score of 3.33 indicates that AORT is not in any danger for bankruptcy at the moment.
  • AORT has a better Altman-Z score (3.33) than 70.11% of its industry peers.
  • AORT has a debt to FCF ratio of 260.47. This is a negative value and a sign of low solvency as AORT would need 260.47 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 260.47, AORT is in the better half of the industry, outperforming 67.39% of the companies in the same industry.
  • AORT has a Debt/Equity ratio of 0.49. This is a healthy value indicating a solid balance between debt and equity.
  • AORT has a Debt to Equity ratio (0.49) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 260.47
Altman-Z 3.33
ROIC/WACC0.22
WACC10.14%
AORT Yearly LT Debt VS Equity VS FCFAORT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M

2.3 Liquidity

  • AORT has a Current Ratio of 3.53. This indicates that AORT is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of AORT (3.53) is better than 60.87% of its industry peers.
  • AORT has a Quick Ratio of 2.62. This indicates that AORT is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Quick ratio value of 2.62, AORT is doing good in the industry, outperforming 60.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.53
Quick Ratio 2.62
AORT Yearly Current Assets VS Current LiabilitesAORT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. AORT Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 141.86% over the past year.
  • The Earnings Per Share has been decreasing by -4.78% on average over the past years.
  • AORT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.59%.
  • Measured over the past years, AORT shows a quite strong growth in Revenue. The Revenue has been growing by 11.75% on average per year.
EPS 1Y (TTM)141.86%
EPS 3YN/A
EPS 5Y-4.78%
EPS Q2Q%112.82%
Revenue 1Y (TTM)13.59%
Revenue growth 3Y12.04%
Revenue growth 5Y11.75%
Sales Q2Q%19.2%

3.2 Future

  • AORT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 70.33% yearly.
  • Based on estimates for the next years, AORT will show a quite strong growth in Revenue. The Revenue will grow by 12.25% on average per year.
EPS Next Y102.54%
EPS Next 2Y107.21%
EPS Next 3Y69.87%
EPS Next 5Y70.33%
Revenue Next Year11.86%
Revenue Next 2Y11.51%
Revenue Next 3Y11.73%
Revenue Next 5Y12.25%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
AORT Yearly Revenue VS EstimatesAORT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M
AORT Yearly EPS VS EstimatesAORT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2

More info and screens

Find the best growth stocksShow best growing peers

4

4. AORT Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 210.14, AORT can be considered very expensive at the moment.
  • Based on the Price/Earnings ratio, AORT is valued a bit cheaper than 63.59% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of AORT to the average of the S&P500 Index (25.96), we can say AORT is valued expensively.
  • AORT is valuated quite expensively with a Price/Forward Earnings ratio of 103.75.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of AORT indicates a somewhat cheap valuation: AORT is cheaper than 65.22% of the companies listed in the same industry.
  • AORT's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 24.04.
Industry RankSector Rank
PE 210.14
Fwd PE 103.75
AORT Price Earnings VS Forward Price EarningsAORT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200

4.2 Price Multiples

  • 67.39% of the companies in the same industry are more expensive than AORT, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, AORT is valued a bit cheaper than the industry average as 67.39% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 2158.59
EV/EBITDA 39.52
AORT Per share dataAORT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates AORT does not grow enough to justify the current Price/Earnings ratio.
  • A more expensive valuation may be justified as AORT's earnings are expected to grow with 69.87% in the coming years.
PEG (NY)2.05
PEG (5Y)N/A
EPS Next 2Y107.21%
EPS Next 3Y69.87%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. AORT Dividend Analysis

5.1 Amount

  • AORT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AORT Fundamentals: All Metrics, Ratios and Statistics

ARTIVION INC

NYSE:AORT (3/17/2026, 9:45:25 AM)

37.825

+0.43 (+1.14%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-12
Earnings (Next)05-04
Inst Owners88.38%
Inst Owner ChangeN/A
Ins Owners4.23%
Ins Owner Change5.62%
Market Cap1.81B
Revenue(TTM)441.33M
Net Income(TTM)9.76M
Analysts83.08
Price Target52.46 (38.69%)
Short Float %3.58%
Short Ratio3.87
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)101.61%
Min EPS beat(2)-39.98%
Max EPS beat(2)243.19%
EPS beat(4)3
Avg EPS beat(4)555.79%
Min EPS beat(4)-39.98%
Max EPS beat(4)1928.24%
EPS beat(8)5
Avg EPS beat(8)220.91%
EPS beat(12)7
Avg EPS beat(12)112.9%
EPS beat(16)11
Avg EPS beat(16)108.2%
Revenue beat(2)0
Avg Revenue beat(2)-1.72%
Min Revenue beat(2)-2.32%
Max Revenue beat(2)-1.12%
Revenue beat(4)2
Avg Revenue beat(4)0.33%
Min Revenue beat(4)-2.32%
Max Revenue beat(4)2.59%
Revenue beat(8)3
Avg Revenue beat(8)-0.34%
Revenue beat(12)7
Avg Revenue beat(12)0.64%
Revenue beat(16)9
Avg Revenue beat(16)0.45%
PT rev (1m)-0.55%
PT rev (3m)-0.55%
EPS NQ rev (1m)-1.22%
EPS NQ rev (3m)-1.22%
EPS NY rev (1m)-19.32%
EPS NY rev (3m)-20.77%
Revenue NQ rev (1m)2.61%
Revenue NQ rev (3m)2.61%
Revenue NY rev (1m)0.81%
Revenue NY rev (3m)0.81%
Valuation
Industry RankSector Rank
PE 210.14
Fwd PE 103.75
P/S 4.1
P/FCF 2158.59
P/OCF 45.41
P/B 4.04
P/tB 48.11
EV/EBITDA 39.52
EPS(TTM)0.18
EY0.48%
EPS(NY)0.36
Fwd EY0.96%
FCF(TTM)0.02
FCFY0.05%
OCF(TTM)0.83
OCFY2.2%
SpS9.22
BVpS9.36
TBVpS0.79
PEG (NY)2.05
PEG (5Y)N/A
Graham Number6.16
Profitability
Industry RankSector Rank
ROA 1.1%
ROE 2.18%
ROCE 3.41%
ROIC 2.26%
ROICexc 2.46%
ROICexgc 5.74%
OM 6.06%
PM (TTM) 2.21%
GM 64.4%
FCFM 0.19%
ROA(3y)-1.48%
ROA(5y)-1.76%
ROE(3y)-4.5%
ROE(5y)-5.02%
ROIC(3y)2.51%
ROIC(5y)N/A
ROICexc(3y)2.72%
ROICexc(5y)N/A
ROICexgc(3y)6.7%
ROICexgc(5y)N/A
ROCE(3y)3.8%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y12.65%
ROICexc growth 3YN/A
ROICexc growth 5Y23.53%
OM growth 3YN/A
OM growth 5Y12.17%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.07%
GM growth 5Y-0.57%
F-Score7
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 260.47
Debt/EBITDA 4.43
Cap/Depr 173.84%
Cap/Sales 8.85%
Interest Coverage 0.95
Cash Conversion 81.05%
Profit Quality 8.6%
Current Ratio 3.53
Quick Ratio 2.62
Altman-Z 3.33
F-Score7
WACC10.14%
ROIC/WACC0.22
Cap/Depr(3y)84.09%
Cap/Depr(5y)70.92%
Cap/Sales(3y)4.61%
Cap/Sales(5y)4.32%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)141.86%
EPS 3YN/A
EPS 5Y-4.78%
EPS Q2Q%112.82%
EPS Next Y102.54%
EPS Next 2Y107.21%
EPS Next 3Y69.87%
EPS Next 5Y70.33%
Revenue 1Y (TTM)13.59%
Revenue growth 3Y12.04%
Revenue growth 5Y11.75%
Sales Q2Q%19.2%
Revenue Next Year11.86%
Revenue Next 2Y11.51%
Revenue Next 3Y11.73%
Revenue Next 5Y12.25%
EBIT growth 1Y-0.48%
EBIT growth 3YN/A
EBIT growth 5Y25.35%
EBIT Next Year219.45%
EBIT Next 3Y66.04%
EBIT Next 5Y45.21%
FCF growth 1Y-92.41%
FCF growth 3YN/A
FCF growth 5Y-30.14%
OCF growth 1Y79.35%
OCF growth 3YN/A
OCF growth 5Y26.38%

ARTIVION INC / AORT Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ARTIVION INC?

ChartMill assigns a fundamental rating of 5 / 10 to AORT.


What is the valuation status of ARTIVION INC (AORT) stock?

ChartMill assigns a valuation rating of 4 / 10 to ARTIVION INC (AORT). This can be considered as Fairly Valued.


Can you provide the profitability details for ARTIVION INC?

ARTIVION INC (AORT) has a profitability rating of 5 / 10.


What are the PE and PB ratios of ARTIVION INC (AORT) stock?

The Price/Earnings (PE) ratio for ARTIVION INC (AORT) is 210.14 and the Price/Book (PB) ratio is 4.04.